T
Tony Lopez
1
APPEARANCES
1
PODCASTS
012
DEC 30
JAN 6
JAN 13
JAN 20
JAN 27
FEB 3
FEB 10
FEB 17
FEB 24
MAR 3
MAR 10
MAR 17
MAR 24
MAR 31
APR 7
APR 14
APR 21
APR 28
MAY 5
MAY 12
MAY 19
MAY 26
JUN 2
JUN 9
JUN 16
JUN 23
JUN 30
JUL 7
JUL 14
JUL 21
JUL 28
AUG 4
AUG 11
AUG 18
AUG 25
SEP 1
SEP 8
SEP 15
SEP 22
SEP 29
OCT 6
OCT 13
OCT 20
OCT 27
NOV 3
NOV 10
NOV 17
NOV 24
DEC 1
DEC 8
DEC 15
DEC 22
DEC 29
JAN 5
JAN 12
JAN 19
JAN 26
FEB 2
FEB 9
FEB 16
FEB 23
MAR 2
MAR 9
MAR 16
MAR 23
MAR 30
APR 6
APR 13
APR 20
APR 27
MAY 4
MAY 11
MAY 18
MAY 25
JUN 1
JUN 8
JUN 15
JUN 22
JUN 29
JUL 6
JUL 13
JUL 20
JUL 27
AUG 3
AUG 10
AUG 17
AUG 24
AUG 31
SEP 7
SEP 14
SEP 21
SEP 28
OCT 5
OCT 12
OCT 19
OCT 26
NOV 2
NOV 9
Jun 25, 2026
Title: MedTech Regulations, AI, & Scaling: A new partnership with TAG + AVS Life Sciences
T
10:10Tony LopezGUEST
There is, and it's an important one, right? Because You know, and I have very, very many examples that I can give specifically as to how the interaction goes between, I'll say, the commercial teams and the operational teams that are developing the product, even the R&D teams that are developing the product.
T
10:29Tony LopezGUEST
Because you kind of have to think about the entire lifecycle of the product, right? You go from the laboratory, you've developed an example product that we developed years ago and I was involved with at Ethicon, the first antibacterial suture.
T
10:43Tony LopezGUEST
Big deal, right? You're developing an antibacterial suture for the first time, and who better than Ethicon to do that, the world leader in sutures, right? So from a laboratory perspective, you got this wonderful petri dish that shows that this suture, when surrounded by microorganisms, actually affects them and doesn't allow the microorganisms to grow on the suture.
T
11:05Tony LopezGUEST
That's a big deal, clinically speaking, right? So you go from that idea in the R&D and in the lab, and you say, how do I produce that? Right? How do I produce that? So the first step is, can I scale this? Can I produce this in large quantities, right? And what's the manufacturing process? And then you start asking yourself the question earlier in the process, early in the development process, not only can I make it, but how do I prove it? How do I prove its efficacy? How do I prove that it does what it's supposed to do? Right.
T
11:37Tony LopezGUEST
And what can I say about what it does? And you start thinking about those things because you're really starting to think about what's the FDA going to require for me in order for me to be able to show that I'm doing these things.
16 MINS LATER
J
28:04Justin StarbirdHOST
What made AVS jump into that and look at that as a viable option for potential ways to earn new business?